Adjuvant therapy for breast cancer

被引：20

作者：

Hortobagyi, G ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

来源：

ANNUAL REVIEW OF MEDICINE | 2000年 / 51卷

关键词：

chemotherapy; hormonal therapy;

D O I：

10.1146/annurev.med.51.1.377

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

substantial progress has been made in the diagnosis and management of primary breast cancer over the past three decades. As a result, mortality related to this disease has been decreasing gradually for several years, treatment has become more effective, and side effects and complications related to treatment have decreased. In this report, we review the state of adjuvant therapy for breast cancer.

引用

页码：377 / 392

页数：16

共 66 条

[1]

ABE O, 1992, LANCET, V339, P71

[2]

ABE O, 1995, NEW ENGL J MED, V333, P1444

[3]

Abe O, 1998, LANCET, V352, P930

[4]

Abeloff M D, 1988, Oncology (Williston Park), V2, P21

[5] High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America [J].

Antman, KH ;

Rowlings, PA ;

Vaughan, WP ;

Pelz, CJ ;

Fay, JW ;

Fields, KK ;

Freytes, CO ;

Gale, RP ;

Hillner, BE ;

Holland, HK ;

Kennedy, MJ ;

Klein, JP ;

Lazarus, HM ;

McCarthy, PL ;

Saez, R ;

Spitzer, G ;

Stadtmauer, EA ;

Williams, SF ;

Wolff, S ;

Sobocinski, KA ;

Armitage, JO ;

Horowitz, MM .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :1870-1879

[6]

ANTMAN KH, 1992, HIGH DOSE CANCER THE, P701

[7]

BEZWODA WR, 1999, P AN M AM SOC CLIN, V18, pA2

[8] Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer [J].

Bines, J ;

Oleske, DM ;

Cobleigh, MA .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1718-1729

[9]

BONADONNA G, 1995, JAMA-J AM MED ASSOC, V273, P542

[10]

Buzdar AU, 1997, ADJ THER CANC, V8, P93

← 1 2 3 4 5 6 7 →